SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-20-007998
Filing Date
2020-04-20
Accepted
2020-04-20 07:31:03
Documents
5
Effectiveness Date
2020-04-20

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dmtp20200414_defa14a.htm DEFA14A 19689
2 notice01.jpg GRAPHIC 117300
3 notice02.jpg GRAPHIC 176402
4 notice03.jpg GRAPHIC 52052
5 notice04.jpg GRAPHIC 19997
  Complete submission text file 0001437749-20-007998.txt   524674
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36291 | Film No.: 20801254
SIC: 2834 Pharmaceutical Preparations